The Biotech Growth Trust Plc - Net Asset Value(s) PR Newswire London, May 21 THE BIOTECH GROWTH TRUST PLC NET ASSET VALUE The estimated un-audited net asset value
The Biotech Growth Trust Plc - Net Asset Value(s)
PR Newswire
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 7 May 2021 was 1333.79p (ex income) 1333.38p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
FNRD-2.621.0
Wie bewerten Sie die aktuell angezeigte Seite?sehr gut123456schlechtProblem melden
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen,
The Biotech Growth Trust Plc - Net Asset Value(s)
PR Newswire
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 5 May 2021 was 1358.23p (ex income) 1357.82p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
FNRD-2.621.0
Wie bewerten Sie die aktuell angezeigte Seite?sehr gut123456schlechtProblem melden
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen,
The Biotech Growth Trust Plc - Compliance with Market Abuse Regulation
PR Newswire
Compliance with Market Abuse Regulation
4 May 2021
The Company confirms that:
a) all inside information which the Directors and Company may have had has been notified to a Regulated Information Service ( RIS );
b) the Company s net asset value per share is calculated and announced through a RIS on a daily basis;
c) the Company has no reason to believe that there will be any material difference between the net asset value per share as at close of business on Wednesday 31 March 2021, which was announced on Thursday, 1 April 2021, and the financial information to be published in the announcement of its results for the year ended 31 March 2021.
The Biotech Growth Trust Plc - Total Voting Rights
PR Newswire
4 May 2021
Voting Rights and Capital
In accordance with the Financial Conduct Authority s Disclosure Guidance and Transparency Rules, The Biotech Growth Trust PLC announces the following:
As at 30 April 2021, The Biotech Growth Trust PLC s capital consists of ordinary shares of 25p with each ordinary share holding one voting right. The total number of ordinary shares in issue is 41,664,769. The Company has no ordinary shares in Treasury.
Therefore, the total number of voting rights in The Biotech Growth Trust PLC is 41,664,769.
The above figure (41,664,769) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in The Biotech Growth Trust PLC, or a change to their interest in The Biotech Growth Trust PLC, under the Financial Conduct Authority s Disclosure Guidance and Transparency Rules.